Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Divergent Effects of GnRH Agonist and GnRH Antagonist Treatment on Platelet Activity and Transcriptome.
Journal: JACC. CardioOncology
Published: January 30, 2026
Evaluating indeterminate bone lesions and lymph nodes on PSMA-PET: a multidisciplinary consensus algorithm and 1-year implementation results.
Journal: European radiology
Published: September 29, 2025
Pembrolizumab in Combination With Gemcitabine and Concurrent Hypofractionated Radiation Therapy as Bladder-sparing Treatment for Muscle-invasive Urothelial Cancer of the Bladder: A Multicenter Phase 2 Trial.
Journal: European urology
Published: September 26, 2025
Evaluating extraprostatic extension of prostate cancer: pragmatic integration of MRI and PSMA-PET/CT.
Journal: Abdominal radiology (New York)
Published: March 02, 2025
Using patient-reported outcomes from the PROCLAIM trial to assess the impact of universal germline genetic testing for prostate cancer patients.
Journal: Prostate cancer and prostatic diseases
Published: February 19, 2025
Cyclin-Dependent Kinase Inhibition in Prostate Cancer: Past, Present, and Future.
Journal: Cancers
Published: January 15, 2025
PSMA-avid rib lesions in prostate cancer patients: differentiating false positives from metastatic disease.
Journal: European radiology
Published: December 19, 2024
Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now.
Journal: JCO oncology practice
Published: December 19, 2024
In Vivo Efficacy of a Macrocyclic Peptoid-Peptide Hybrid That Selectively Modulates the Beta-Catenin/TCF Interaction to Inhibit Prostate Cancer.
Journal: The Prostate
Published: October 28, 2024
Clinician-Reported Management Recommendations in Response to Universal Germline Genetic Testing in Patients With Prostate Cancer.
Journal: The Journal of urology
Published: August 09, 2024
Last Updated: 09/26/2026